Opportunity Information: Apply for CDC RFA PS13 1301
Apply for CDC RFA PS13 1301
- The Centers for Disease Control and Prevention in the health sector is offering a public funding opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.116 Project Grants and Cooperative Agreements for Tuberculosis Control Programs.
- This funding opportunity was created on Jun 21, 2012 and posted on Jun 21, 2012.
- Applicants must submit their applications by Aug 31, 2012. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The funding agency has allocated a total of $19,705,785.00 to eligible and selected applicants.
- Each selected applicant is eligible to receive up to $1,017,670.00 in funding.
- The number of recipients for this funding is limited to 6 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Eligible Applicants Eligibility is limited to health departments or their bona fide agents in the six U.S. affiliated Pacific Islands jurisdictions including the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. The Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau, are the only ones who have the jurisdictional authority and mandate to carry out these services in these freely affiliated Pacific Islands and territories. Activities identified in this FOA constitute activities from FOA PS10 1002 HIV Prevention Projects for the Pacific Islands, DHAP PS08 802 HIV/AIDS Surveillance, PS09 902 Comprehensive STD Prevention Services, and PS10 1005 TB Elimination and Laboratory Cooperative Agreements for the entities identified above.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The grant opportunity titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands" is a CDC discretionary funding program offered as a cooperative agreement. Its central goal is to strengthen and modernize core public health prevention and treatment work across four major disease areas HIV, viral hepatitis, sexually transmitted diseases, and tuberculosis in the U.S. affiliated Pacific Islands (USAPIs). Rather than funding these areas through separate, siloed grants, the CDC designed this opportunity to integrate activities and expectations into a single announcement, with the idea that jurisdictions can deliver services more efficiently while also reducing duplicated effort, reporting, and administrative workload.
A major emphasis of the program is service integration. The announcement highlights optimizing public health service delivery by expanding opportunities to screen, test, treat, and where appropriate vaccinate people who need these services. The logic is practical: many populations and clinical settings overlap across HIV, hepatitis, STDs, and TB, so a more coordinated approach can increase the number of people reached and improve continuity of care. The FOA also explicitly encourages collaboration across program areas and improvements in operations through shared data systems, which signals a focus on building stronger public health infrastructure rather than only supporting individual disease programs in isolation.
Another core theme is support for cross-cutting activities that benefit multiple disease areas at once. The FOA calls out surveillance, screening, evaluation, and data systems as examples of these shared functions. In practice, this means strengthening how jurisdictions track cases and trends, manage and analyze public health data, evaluate program performance, and use information to guide decision-making across HIV, viral hepatitis, STDs, and TB. By emphasizing common systems and integrated workflows, the CDC is aiming to improve public health responsiveness and reduce inefficiencies that can happen when each disease program maintains separate processes.
This opportunity is specifically targeted to the six U.S. affiliated Pacific Islands jurisdictions that have the authority and mandate to carry out these public health services. Eligibility is limited to the health departments or their bona fide agents in the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau. The eligibility language is narrow by design, reflecting that these entities are the recognized jurisdictions responsible for implementing population-level prevention, surveillance, and treatment support across these islands and territories.
From an administrative standpoint, the funding announcement is positioned as a consolidation of requirements from four earlier CDC funding opportunities: PS10-1002 (HIV Prevention Projects for the Pacific Islands), PS08-802 (HIV/AIDS Surveillance), PS09-902 (Comprehensive STD Prevention Services), and PS10-1005 (TB Elimination and Laboratory Cooperative Agreements). By combining these into a single integrated FOA, the CDC intended to streamline applications, minimize administrative burden, and reduce duplication across multiple grants that may have previously required separate applications, reports, and parallel program structures. The cooperative agreement mechanism also indicates that CDC program staff are expected to have substantial involvement in the work, which typically includes technical assistance, collaboration on planning and evaluation, and alignment with federal program expectations.
Financially, the opportunity (Funding Opportunity Number CDC RFA PS13-1301) anticipated six awards, aligning with the six eligible jurisdictions. The estimated total funding listed is $19,705,785. The award ceiling is $1,017,670, and the award floor is listed as $0, which usually means awards may vary significantly based on jurisdictional plans, needs, and final CDC funding decisions rather than guaranteeing a minimum amount. The CFDA number referenced is 93.116, associated with tuberculosis control program grants and cooperative agreements. The opportunity also indicates a cost sharing or matching requirement, meaning recipients are expected to contribute some level of non-federal support (the specific amount and rules would normally be detailed in the full announcement).
Key dates in the listing show the FOA was posted June 21, 2012, with an original and current closing date of August 31, 2012, and an archive date of September 30, 2012. For applicants at the time, the timeline implied a relatively short window to develop an integrated proposal that covered multiple disease areas and the supporting infrastructure needed to manage them together.
For help accessing the full announcement, the listing provides a CDC Procurement and Grants Office contact point, including phone and email. Overall, the opportunity is best understood as a coordinated public health capacity and service-delivery investment for the USAPIs, designed to strengthen prevention and treatment for four interconnected disease areas while making programs more integrated, data-driven, and administratively manageable.
Frequently Asked Questions (FAQs)
What is the title of this grant opportunity?
The opportunity is titled "Accelerating the Prevention and Control of HIV/AIDS, Viral Hepatitis, STDs and TB in the U.S. Affiliated Pacific Islands."
Which agency is offering this funding?
The funding is offered by the Centers for Disease Control and Prevention (CDC) as a discretionary funding program.
What type of funding mechanism is used?
This opportunity is offered as a cooperative agreement, which generally means CDC program staff are expected to have substantial involvement in the funded work (for example, collaboration on planning and evaluation and providing technical assistance).
What is the main purpose of the program?
The central goal is to strengthen and modernize core public health prevention and treatment work across four disease areas: HIV, viral hepatitis, sexually transmitted diseases (STDs), and tuberculosis (TB) in the U.S. Affiliated Pacific Islands (USAPIs).
Which disease areas are included in the integrated approach?
The FOA integrates expectations and activities across HIV, viral hepatitis, STDs, and TB into a single announcement rather than funding them through separate, siloed grants.
Why did CDC combine multiple disease areas into one announcement?
The design is intended to help jurisdictions deliver services more efficiently and reduce duplicated effort, reporting, and administrative workload by consolidating activities that often overlap across programs.
What does "service integration" mean in this FOA?
Service integration refers to optimizing public health service delivery by expanding opportunities to screen, test, treat, and, where appropriate, vaccinate people who need these services. The FOA emphasizes coordination because many populations and clinical settings overlap across HIV, hepatitis, STDs, and TB.
What kinds of cross-cutting activities does the FOA emphasize?
The FOA highlights cross-cutting functions that can benefit multiple disease areas at once, including surveillance, screening, evaluation, and data systems.
How does the FOA address data systems and infrastructure?
The announcement signals an emphasis on shared data systems and integrated workflows to strengthen how jurisdictions track cases and trends, manage and analyze public health data, evaluate program performance, and use information to guide decision-making across the four disease areas.
Who is eligible to apply?
Eligibility is limited to the health departments (or their bona fide agents) of the six U.S. affiliated Pacific Islands jurisdictions that have the authority and mandate to carry out these public health services.
Which jurisdictions are eligible under this opportunity?
The eligible jurisdictions are the Commonwealth of the Northern Mariana Islands, American Samoa, Guam, the Federated States of Micronesia, the Republic of the Marshall Islands, and the Republic of Palau.
Is eligibility open to universities, hospitals, or nonprofits outside these jurisdictions?
Based on the eligibility language provided, eligibility is narrow by design and is limited to the listed health departments or their bona fide agents in the six jurisdictions.
What is the Funding Opportunity Number (FOA number)?
The Funding Opportunity Number listed is CDC RFA PS13-1301.
How many awards were anticipated?
The announcement anticipated six awards, aligning with the six eligible jurisdictions.
What is the estimated total funding amount?
The estimated total funding listed is $19,705,785.
What is the award ceiling?
The award ceiling is listed as $1,017,670.
What is the award floor and what does it imply?
The award floor is listed as $0. This typically indicates awards may vary significantly based on jurisdictional plans, needs, and final CDC funding decisions, rather than guaranteeing a minimum award amount.
Is there a cost sharing or matching requirement?
Yes. The opportunity indicates a cost sharing or matching requirement, meaning recipients are expected to contribute some level of non-federal support (the specific amount and rules would normally be detailed in the full announcement).
What earlier CDC funding opportunities were consolidated into this FOA?
This FOA is described as consolidating requirements from four earlier CDC opportunities: PS10-1002 (HIV Prevention Projects for the Pacific Islands), PS08-802 (HIV/AIDS Surveillance), PS09-902 (Comprehensive STD Prevention Services), and PS10-1005 (TB Elimination and Laboratory Cooperative Agreements).
What is the CFDA number referenced in the listing?
The CFDA number referenced is 93.116, associated with tuberculosis control program grants and cooperative agreements.
When was the FOA posted?
The FOA was posted on June 21, 2012.
What was the closing date for applications?
The original and current closing date listed is August 31, 2012.
When was the opportunity archived?
The archive date listed is September 30, 2012.
What does the timeline suggest about the application window?
Based on the dates provided, the timeline implied a relatively short window to develop an integrated proposal covering multiple disease areas and the infrastructure needed to manage them together.
What kind of CDC involvement should recipients expect under a cooperative agreement?
The listing notes that the cooperative agreement mechanism indicates substantial involvement by CDC program staff, which typically includes technical assistance, collaboration on planning and evaluation, and alignment with federal program expectations.
How can someone request help accessing the full announcement?
The listing provides a contact point through the CDC Procurement and Grants Office, including a phone number and an email address, for assistance with accessing the full announcement.
Browse more opportunities from the same agency: Centers for Disease Control and Prevention
Browse more opportunities from the same category: Health
Next opportunity: Womens Mental Health During Pregnancy and the Postpartum Period (R21)
Previous opportunity: Revitalization of Nevada Landscapes
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA PS13 1301
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA PS13 1301) also looked into and applied for these:
| Funding Opportunity |
|---|
| NIAMS Building Interdisciplinary Research Team (BIRT) Revision Awards (R01) Apply for RFA AR 13 003 Funding Number: RFA AR 13 003 Agency: National Institutes of Health Category: Health Funding Amount: $100,000 |
| Functions of Skeletal Muscle beyond Contraction (R01) Apply for PA 12 208 Funding Number: PA 12 208 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Functions of Skeletal Muscle beyond Contraction (R21) Apply for PA 12 209 Funding Number: PA 12 209 Agency: National Institutes of Health Category: Health Funding Amount: $200,000 |
| National HIV Program Apply for HHS 2012 IHS OCPS HIV 0001 Funding Number: HHS 2012 IHS OCPS HIV 0001 Agency: Indian Health Service Category: Health Funding Amount: $90,000 |
| Developmental Behavioral Pediatrics Training Program Apply for HRSA 13 137 Funding Number: HRSA 13 137 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Availability of One year Administrative Supplements to NEI supported Research for FY 2012 (Admin Supp) Apply for PA 12 217 Funding Number: PA 12 217 Agency: National Institutes of Health Category: Health Funding Amount: $500,000 |
| Office of Urban Indian Health Programs Title V HIV/AIDS Apply for HHS 2012 IHS UIHP 0001 Funding Number: HHS 2012 IHS UIHP 0001 Agency: Indian Health Service Category: Health Funding Amount: $60,000 |
| PPHF 2012 National Diabetes Prevention Program Preventing Type 2 Diabetes Among People at High Risk financed solely by 2012 Prevention and Public Health Funds Apply for CDC RFA DP12 1212PPHF12 Funding Number: CDC RFA DP12 1212PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $2,000,000 |
| Building Capacity to Prevent SV through Resources, Training and Technical Assistance Apply for CDC RFA CE12 1203 Funding Number: CDC RFA CE12 1203 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $1,500,000 |
| Rape Prevention and Education Program Apply for CDC RFA CE13 1301 Funding Number: CDC RFA CE13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $3,400,000 |
| PPHF 2012 National Public Health Improvement Initiative (NPHII) Capacity Building Assistance to Strengthen Public Health Infrastructure and Performance financed in part by 2012 Prevention and Public Health Fund Apply for CDC RFA HM08 8050501PPHF12 Funding Number: CDC RFA HM08 8050501PPHF12 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: $700,000 |
| FY12 National Umbrella Cooperative Agreement Program II (NUCA II Program) Apply for MP MPC 12 002 Funding Number: MP MPC 12 002 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $500,000 |
| Health Policy Development Project 2 Apply for RFA 492 12 000030 Funding Number: RFA 492 12 000030 Agency: Philippines USAID Manila Category: Health Funding Amount: $15,000,000 |
| Emergency Medical Services for Children (EMSC) State Partnership Grant Program Apply for HRSA 13 201 Funding Number: HRSA 13 201 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Research on Psychopathology In Intellectual Disabilities (R01) Apply for PA 12 219 Funding Number: PA 12 219 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| PPHF 2012 Cooperative Agreements for Prescription Drug Monitoring Program (PDMP) Electronic Health Record (EHR) Integration and Interoperability Expansion (PPHF 2012) Apply for TI 12 011 Funding Number: TI 12 011 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $225,000 |
| Cooperative Agreement to Support Establishment of the Affordable Care Acts Health Insurance Exchanges Apply for IE HBE 12 001 Funding Number: IE HBE 12 001 Agency: CMS Consumer Information Insurance Oversight Category: Health Funding Amount: Case Dependent |
| NIH Directors Transformative Research Awards (R01) Apply for RFA RM 12 017 Funding Number: RFA RM 12 017 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Dimensional Approaches to Research Classification in Psychiatric Disorders (R01) Apply for RFA MH 13 080 Funding Number: RFA MH 13 080 Agency: National Institutes of Health Category: Health Funding Amount: $400,000 |
| Cooperative Agreement on Immunization with the World Health Organization (WHO) Apply for CDC RFA GH13 1301 Funding Number: CDC RFA GH13 1301 Agency: Centers for Disease Control and Prevention Category: Health Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA PS13 1301", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.